|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,973.20 |
3.35% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$63,605.10 |
3.04% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$54,621.00 |
2.61% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$52,026.04 |
2.49% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$48,934.10 |
2.34% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$49,037.48 |
2.34% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$47,202.15 |
2.26% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$46,855.71 |
2.24% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$45,288.00 |
2.17% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$45,087.79 |
2.16% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$45,004.16 |
2.15% |
| Waters Corporation |
WAT |
941848103 |
120 |
$45,021.60 |
2.15% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,604.15 |
2.13% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$44,274.36 |
2.12% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,163.22 |
2.11% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,217.16 |
2.11% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,161.41 |
2.11% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$43,923.11 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,265.14 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$43,033.26 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,176.80 |
2.06% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,218.00 |
2.02% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$42,146.90 |
2.02% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,110.62 |
2.01% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$41,248.04 |
1.97% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$40,521.20 |
1.94% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$40,419.94 |
1.93% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$39,973.32 |
1.91% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$39,761.25 |
1.90% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$39,517.94 |
1.89% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,470.09 |
1.89% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$38,914.84 |
1.86% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$38,903.47 |
1.86% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$38,593.94 |
1.85% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,618.70 |
1.85% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,868.67 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,910.37 |
1.81% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$37,605.00 |
1.80% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,301.70 |
1.78% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$36,676.33 |
1.75% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$36,214.42 |
1.73% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,849.41 |
1.71% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$35,362.80 |
1.69% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$35,085.72 |
1.68% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$35,230.32 |
1.68% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$32,397.70 |
1.55% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$31,933.09 |
1.53% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$32,100.38 |
1.53% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$30,414.60 |
1.45% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$27,006.38 |
1.29% |
| US Dollar |
$USD |
|
2,738 |
$2,737.77 |
0.13% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|